Cite

HARVARD Citation

    Robin, M. et al. (2018). Alemtuzumab vs anti‐thymocyte globulin in patients transplanted from an unrelated donor after a reduced intensity conditioning. European journal of haematology. pp. 466-474. [Online]. 
  
Back to record